Traws Pharma, Inc.
TRAWNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $4.29M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.39$3.23
- Volume (live)
- -
- Avg. volume (3M)
- 1.12M
Traws Pharma (TRAW) Stock Price & Financial Analysis
Traws Pharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.36 - $0.41 |
|---|---|
| 52-Week High | $3.23 |
| 52-Week Low | $0.39 |
| Open | $0.41 |
| Volume (last close) | 257.31K |
| Average Volume (3M) | 1.12M |
| Revenue (TTM) | 2.79M |
|---|---|
| Net Income (TTM) | -21.57M |
| Free Cash Flow (TTM) | -16.85M |
| EPS (TTM) | −$2.19 |
| Profit Margin | -772.97% |
| Operating Margin | -907.35% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 4.29M |
|---|---|
| Shares Outstanding | 10.64M |
| Price to Sales (P/S) | 1.54 |
| Price to Book (P/B) | -0.81 |
| EV/EBITDA | -0.05 |
| 50-Day MA | $0.54 |
|---|---|
| 200-Day MA | $1.23 |
| 1-Year Change | −85.91% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Traws Pharma at a Glance
As of the Oct 16, 2026 close, Traws Pharma (TRAW) has a market capitalization of $4.29M. The stock trades at 1.5× sales. Over the trailing twelve months it lost $21.57M on revenue of $2.79M and burned $16.85M of free cash flow. Revenue grew 885.9% year over year.
As of its latest reported balance sheet, it holds $3.13M in cash and securities against $0.00 of debt, a net cash position of $3.13M.
Traws Pharma does not currently pay a dividend.
The share price is down 85.9% over the past year. At $0.37 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.39 to $3.23, below its 200-day moving average of $1.23.
Frequently Asked Questions About Traws Pharma
What is the current stock price for TRAW?
As of the Oct 16, 2026 close, TRAW stock trades at $0.37. The 52-week range is $0.39–$3.23, with a day range of $0.36–$0.41.
What is the P/E ratio for TRAW?
The P/E ratio (Price-to-Earnings) for TRAW is shown in the Key Statistics section. This valuation metric helps compare Traws Pharma, Inc. to industry peers.
Does TRAW pay dividends?
Traws Pharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TRAW?
Analyst ratings and recommendations for TRAW are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of TRAW?
As of the Oct 16, 2026 close, Traws Pharma's market capitalization is $3.9M, classifying it as a micro-cap company. Traws Pharma operates in the Healthcare sector within the Biotechnology industry.